Profound Medical Corp
Company Profile
Business description
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Contact
2400 Skymark Avenue
Unit 6
MississaugaONL4W 5K5
CANT: +1 647 476-1350
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
142
Stocks News & Analysis
stocks
Strong finish to the year for overvalued ASX share
stocks
Our three most overvalued ASX shares
stocks
What does big US court decision mean for Google’s parent company Alphabet?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,091.80 | 28.70 | -0.31% |
CAC 40 | 7,734.84 | 35.92 | 0.47% |
DAX 40 | 23,807.13 | 210.15 | 0.89% |
Dow JONES (US) | 45,514.95 | 106.34 | -0.23% |
FTSE 100 | 9,221.44 | 13.23 | 0.14% |
HKSE | 25,633.91 | 215.93 | 0.85% |
NASDAQ | 21,798.70 | 91.01 | 0.42% |
Nikkei 225 | 44,053.14 | 409.33 | 0.94% |
NZX 50 Index | 13,266.58 | 14.56 | -0.11% |
S&P 500 | 6,495.15 | 13.65 | 0.21% |
S&P/ASX 200 | 8,812.20 | 28.70 | -0.32% |
SSE Composite Index | 3,826.84 | 14.33 | 0.38% |